Literature DB >> 19616899

Extensive extranodal metastases of basal-like breast cancer with predominant myoepithelial spindle cell differentiation.

Roman Trepp1, Barbara C Padberg, Zsuzsanna Varga, Richard Cathomas, Roman Inauen, Walter H Reinhart.   

Abstract

A differentiation towards myoepithelial cells has been demonstrated in several types of lesions in the breast. These include multifocal myoepitheliomatosis, the rare mixed tumor or pleomorphic adenoma, adenoid cystic carcinoma, adenomyoepithelioma and myoepithelial carcinoma (malignant myoepithelioma). Myoepithelial carcinoma is the only lesion purely composed of myoepithelial cells. All these tumors are benign and/or of low-grade malignancy, with the exception of malignant myoepithelioma. In contrast to the statement of the current World Health Organization (WHO), recent studies have reported that regional and distant metastases may occur in about 50% of pure myoepithelial carcinomas. The presented case of a breast carcinoma with dominant myoepithelial/spindle cell differentiation in a 58-year-old woman is an excellent example to document the highly aggressive biological behavior of this tumor phenotype. Despite an extensive chemotherapy and radiotherapy, the tumor was rapidly progressive, forming a finally exulcerating local tumor relapse and widespread metastases to the myocardium, lungs, liver, kidneys and skin. Similarities in morphology and biological behavior compared to patients with "triple-negative" (hormone receptor and Her2) monophasic sarcomatoid carcinomas and pure spindle cell sarcomas are discussed. (c) 2009. Published by Elsevier GmbH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616899     DOI: 10.1016/j.prp.2009.06.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  Malignant myoepithelioma of the breast: A case report and review of the literature.

Authors:  Maria Papazian; Ioannis Kalantzis; Georgios Galanopoulos; Iliana Mani; Olympia Tzaida; Ioanna Iacovidou; Nikolaos Ziras
Journal:  Mol Clin Oncol       Date:  2016-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.